SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER
1. Date of Report (Date of earliest event reported) Feb 28, 20222. SEC Identification Number CS2002510643. BIR Tax Identification No. 2190756144. Exact name of issuer as specified in its charter MEDILINES DISTRIBUTORS INCORPORATED5. Province, country or other jurisdiction of incorporation MANDALUYONG CITY6. Industry Classification Code(SEC Use Only) 7. Address of principal office 7 Pioneer St. Corner Sheridan St., Barangay Highway Hills, Mandaluyong CityPostal Code15508. Issuer's telephone number, including area code +6377471016/+63851920129. Former name or former address, if changed since last report NA10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares 2,750,000,800
11. Indicate the item numbers reported herein Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Medilines Distributors IncorporatedMEDIC PSE Disclosure Form 7-2 - Postponement of Annual Stockholders' Meeting References: SRC Rule 17 (SEC Form 17-C) and
Section 7 of the Revised Disclosure Rules
Subject of the Disclosure

Postponement of Annual Stockholders' Meeting

Background/Description of the Disclosure

In its meeting special meeting of the Board of Directors las 18 February 2022, the Board approved the postponement of the Annual Stockholders' Meeting originally scheduled any day of March (March 2022) as per the Company's By-Laws, and has set a new date for the said Annaul Stockholders' Meeting on 6 June 2022.

Date of Approval by Board of Directors Feb 18, 2022
Date of Stockholders' Meeting (as provided in the By-Laws) Any day of March
Reason(s) for postponement

Due to the restrictions imposed by the Alert levels during the month of January and February, the Corporation needs additional time to complete the disclosures and reports required to be filed in relation to the 2022 ASM.

Other Relevant Information

Please find attached the relevant SEC Form 17-C and Secretary's Certificate for the postponement of the Annual Stockholders' Meeting

Filed on behalf by:
Name Simonette Liutongco
Designation Compliance Officer/Internal Auditor/Investor Relations

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Medilines Distributors Inc. published this content on 28 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 February 2022 03:11:03 UTC.